What is Tissue-Grown?
Founded in 1986 and headquartered in Santa Paula, California, Tissue-Grown Corporation specializes in the mass production of disease-indexed horticultural crops, with a particular focus on fruit and nut tree rootstocks. The company leverages commercial micropropagation techniques, integrating them with advanced research in cell genetics and physiology to ensure high-volume, sustainable production. Tissue-Grown is committed to innovation in propagation and is actively pursuing strategic partnerships to scale its operations and meet the growing demand for its specialized rootstocks, including pistachios, coffee, and walnuts.
How much funding has Tissue-Grown raised?
Tissue-Grown has raised a total of $2M across 3 funding rounds:
Debt
$350K
Debt
$600K
Debt
$1.1M
Debt (2020): $350K with participation from PPP
Debt (2021): $600K led by PPP
Debt (2024): $1.1M, investors not publicly disclosed
Key Investors in Tissue-Grown
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Tissue-Grown?
The recent major strategic investment signals a new phase of growth for Tissue-Grown, likely enabling the company to accelerate its expansion plans and further invest in its state-of-the-art research and development facilities. This capital will support the scaling of high-volume projects and potentially facilitate new market entries or product developments. The company's focus on sustainable practices and advanced propagation techniques positions it favorably to capitalize on increasing global demand for high-quality horticultural products.
See full Tissue-Grown company page
